BEHRENS M KATHLEEN bought SRPT
March 10, 2025 · Form 4 insider transaction
BEHRENS M KATHLEEN bought 4,792 shares of Sarepta Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
4,792
Price
$0.00
Total value
N/A
InsiderBEHRENS M KATHLEEN
RoleDirector
SecurityStock Option (right to buy)
Transaction codeA: Grant or award
Transaction dateMarch 10, 2025
Filing dateMarch 11, 2025
Shares owned after4,792
OwnershipDirect
10b5-1 planNo
AmendedNo